News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,359 Results
Type
Article (41573)
Company Profile (259)
Press Release (665527)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (206334)
Career Advice (2037)
Deals (35728)
Drug Delivery (95)
Drug Development (81418)
Employer Resources (172)
FDA (16312)
Job Trends (15049)
News (348555)
Policy (32996)
Tag
Academia (2636)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50236)
ALS (88)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (124)
Approvals (16316)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (364)
Best Places to Work (11705)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2266)
Cardiovascular disease (178)
Career advice (1705)
Career pathing (31)
CAR-T (151)
Cell therapy (424)
Cervical cancer (20)
Clinical research (66175)
Collaboration (839)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2638)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2209)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (271)
Diagnostics (6541)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87084)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (113208)
Executive appointments (726)
FDA (17577)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (106)
Generative AI (19)
Gene therapy (304)
GLP-1 (721)
Government (4464)
Grass and pollen (4)
Guidances (67)
Healthcare (18949)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2783)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16578)
IRA (40)
Job creations (3752)
Job search strategy (1449)
Kidney cancer (10)
Labor market (38)
Layoffs (471)
Leadership (18)
Legal (8027)
Liver cancer (75)
Lung cancer (323)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13443)
Medtech (13448)
Mergers & acquisitions (19696)
Metabolic disorders (689)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1927)
NextGen: Class of 2025 (6550)
Non-profit (4536)
Now hiring (39)
Obesity (366)
Opinion (207)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (47)
People (57935)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20631)
Phase II (29119)
Phase III (21705)
Pipeline (1208)
Policy (139)
Postmarket research (2584)
Preclinical (8856)
Press Release (67)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (379)
Real estate (6119)
Recruiting (65)
Regulatory (22588)
Reports (46)
Research institute (2382)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (132)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3621)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (693)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (140)
Last 7 days (899)
Last 30 days (2633)
Last 365 days (32863)
2025 (10788)
2024 (35421)
2023 (40333)
2022 (51424)
2021 (56013)
2020 (54490)
2019 (46957)
2018 (35320)
2017 (32506)
2016 (31973)
2015 (37999)
2014 (31857)
2013 (26978)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38649)
Australia (6324)
California (6156)
Canada (2027)
China (526)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (83271)
Florida (913)
Georgia (207)
Idaho (57)
Illinois (538)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (900)
Massachusetts (4581)
Michigan (220)
Minnesota (395)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1735)
New Mexico (29)
New York (1753)
North Carolina (986)
North Dakota (8)
Northern California (2685)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (23)
South Dakota (1)
Southern California (2315)
Tennessee (101)
Texas (913)
United States (23238)
Utah (182)
Virginia (146)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (55)
707,359 Results for "idexx laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - February 20, 2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming conferences.
February 20, 2024
·
1 min read
Genetown
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis.
June 4, 2024
·
5 min read
Genetown
IDEXX Laboratories Schedules Two Institutional Investor Events
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events.
December 7, 2023
·
1 min read
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
IDEXX Laboratories, Inc. announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples.
January 12, 2024
·
6 min read
Business
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.
January 23, 2024
·
1 min read
Business
IDEXX Laboratories Announces 2023 Third Quarter Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results.
November 1, 2023
·
33 min read
Press Releases
IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma
January 23, 2025
·
6 min read
Business
IDEXX Announces Fourth Quarter and Full Year 2023 Results
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced fourth quarter and full year results.
February 5, 2024
·
35 min read
Business
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens.
October 5, 2023
·
1 min read
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
IDEXX Laboratories, Inc. announced the expansion of its Fecal Dx ® antigen testing platform with the addition of Cystoisospora.
January 12, 2024
·
6 min read
1 of 70,736
Next
